Table 2. Group comparisons by biochemical assessment.
| SH (nmol/mg protein) (Mean[SD]) | MDA (µmol/g wet tissue) (Mean[SD]) | MPO (Δabs/min/ g tissue) (Mean[SD]) | Total Nitrite (nmol/mg wet tissue) (Mean[SD]) | Urea mg/dL (Mean[SD]) | Kreatin mg/dL (Mean[SD]) | |
|---|---|---|---|---|---|---|
| Montelukast | (45.09[6.73]) | (4.46[.25]) | (.073[.004]) | (.050[.005]) | (103.33[5.27]) | (1.02[.064]) |
| NAC | (50.94[8.58]) | (4.04[.43]) | (.062[.011]) | (.049[.010]) | (113.33[13.54]) | (1.10[.104]) |
| Placebo | (97.09[19.70]) | (6.92[.99]) | (.134[.030]) | (.070[.006]) | (180.0[11.05]) | (1.48[.058]) |
| Sham treated | (39.22[4.31]) | (5.70[1.13]) | (.0460[.003]) | (.032[.006]) | (45.0[2.88]) | (.766[.033]) |
| P Value:* | ||||||
| Montelukast vs placebo | .002 | .027 | .024 | .038 | .000 | .000 |
| Montelukast vs NAC | .536 | .145 | .354 | .565 | .266 | .562 |
| NAC vs placebo | .005 | .003 | .015 | .031 | .003 | .012 |
| Montelukast vs sham treated | .782 | .229 | .033 | .052 | .012 | .060 |
| NAC vs sham treated | .309 | .309 | .354 | .354 | .051 | .112 |
*For SH, MDA, MPO and total nitrite overall group comparisons Mann-Whitney U and Kruskal wallis test P<.05.